RPG Life Sciences
NSE: RPGLIFE · ISIN INE105J01010 · Healthcare
₹2,627.70+48.70 (+1.89%)
Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.
Price chart
₹2,627.70 +48.70 (+1.89%) today
The day
- Previous close
- ₹2,579.00
- Open
- ₹2,573.00
- Day high
- ₹2,649.30
- Day low
- ₹2,573.00
Listed on NSE since 10 June 2008.
Key numbers
- Market value
- ₹4,342.15 Cr
- P/E (trailing)
- 39.57
- EPS (trailing)
- ₹66.35
- Price to book
- 5.95
- Dividend yield
- 0.93%
- Return on equity
- 15.6%
- Debt to equity
- 0.03
- Profit margin
- 14.3%
- Beta
- -0.05
- Volume today
- 6,539
- Average volume
- 27,471
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹509.08 Cr | ₹67.64 Cr |
| FY24 | ₹577.48 Cr | ₹87.66 Cr |
| FY25 | ₹647.54 Cr | ₹183.24 Cr |
| FY26 | ₹702.00 Cr | ₹115.17 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹212 Cr | ₹27 Cr | – |
| Q1 FY27Apr–Jun 2026 | ₹196 Cr | ₹0 | – |
| Q4 FY26Jan–Mar 2026Audited | ₹177 Cr | ₹30 Cr | – |
| Q3 FY26Oct–Dec 2025 | ₹180 Cr | ₹0 | – |
Source: RPG Life Sciences’s results filed with NSE, consolidated (the whole group). Net profit is the share of RPG Life Sciences’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹371 Cr | ₹212 Cr |
| Investments | ₹165 Cr | ₹84 Cr |
| Inventories | ₹173 Cr | ₹124 Cr |
| Owed by customers | ₹141 Cr | ₹117 Cr |
| Cash and equivalents | ₹111 Cr | ₹150 Cr |
| Total assets | ₹1,116 Cr | ₹793 Cr |
| Borrowings | ₹22 Cr | ₹20 Cr |
| Total liabilities | ₹250 Cr | ₹188 Cr |
| Shareholders’ equity | ₹687 Cr | ₹605 Cr |
Source: RPG Life Sciences’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About RPG Life Sciences
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and domestic and international finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
- Industry
- Drug Manufacturers - Specialty & Generic
- Based in
- Mumbai
- Employees
- 1,366
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name RPG Life Sciences in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 24 Per Share
Dividend · ex-date 9 July 2026
- Dividend - Rs 20 Per Share/ Special Dividend - Rs 4 Per Share
Dividend · ex-date 27 June 2025
- Dividend - Rs 16 Per Share
Dividend · ex-date 28 June 2024
- Dividend - Rs 12 Per Share
Dividend · ex-date 21 July 2023
- Dividend - Rs 9.60 Per Share
Dividend · ex-date 14 July 2022 · record date 15 July 2022
- Dividend - Rs 7.20 Per Share
Dividend · ex-date 13 August 2021 · record date 17 August 2021
- Interim Dividend - Rs 4 Per Share
Dividend · ex-date 24 March 2020 · record date 26 March 2020
- Annual General Meeting/ Dividend - Rs 2.40 Per Share
Dividend · ex-date 22 July 2019
Source: NSE. Latest first, 8 of 20.
Information only, not investment advice. Prices are delayed.